RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Cash from operations

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndCash from operations (Million USD)YoY (%)
Jun 30, 20251,752+25.00%
Jun 30, 20241,401+102.11%
Jun 30, 2023693+97.44%
Jun 30, 2022351-52.34%
Jun 30, 2021737-8.17%
Jun 30, 2020802+74.76%
Jun 30, 2019459-9.10%
Jun 30, 2018505+21.97%
Jun 30, 2017414-24.43%
Jun 30, 2016548+43.00%
Jun 30, 2015383-2.07%
Jun 30, 2014391-2.87%
Jun 30, 2013403+5.13%
Jun 30, 2012383+35.30%
Jun 30, 2011283

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)